• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡拉西坦——一种具有新特性的老药?

Piracetam--an old drug with novel properties?

作者信息

Winnicka Katarzyna, Tomasiak Marian, Bielawska Anna

机构信息

Department of Drug Technology, Medical University of Białystok, 1 Kilińskiego Str., 15-089 Białystok, Poland.

出版信息

Acta Pol Pharm. 2005 Sep-Oct;62(5):405-9.

PMID:16459490
Abstract

Piracetam (2-oxo-1-pyrrolidine-acetamide), the most common of the nootropic drugs, is a cyclic derivative of gamma-aminobutyric acid. The treatment with piracetam improves learning, memory, brain metabolism, and capacity. Piracetam has been shown to alter the physical properties of the plasma membrane by increasing its fluidity and by protecting the cell against hypoxia. It increases red cell deformability and normalizes aggregation of hyperactive platelets. Piracetam is an agent with antithrombotic, neuroprotective and rheological properties. The interaction of this molecule with the membrane phospholipids restores membrane fluidity and could explain the efficacy of piracetam in various disorders ranging from dementia and vertigo to myoclonus and stroke.

摘要

吡拉西坦(2-氧代-1-吡咯烷乙酰胺)是最常见的促智药,是γ-氨基丁酸的环状衍生物。使用吡拉西坦进行治疗可改善学习、记忆、脑代谢和能力。已证明吡拉西坦可通过增加质膜流动性和保护细胞免受缺氧来改变质膜的物理性质。它可增加红细胞变形能力并使活性过高的血小板聚集正常化。吡拉西坦是一种具有抗血栓形成、神经保护和流变学特性的药物。该分子与膜磷脂的相互作用可恢复膜流动性,并可解释吡拉西坦在从痴呆、眩晕到肌阵挛和中风等各种疾病中的疗效。

相似文献

1
Piracetam--an old drug with novel properties?吡拉西坦——一种具有新特性的老药?
Acta Pol Pharm. 2005 Sep-Oct;62(5):405-9.
2
Piracetam: novelty in a unique mode of action.吡拉西坦:作用方式独特,别具新颖性。
Pharmacopsychiatry. 1999 Mar;32 Suppl 1:2-9. doi: 10.1055/s-2007-979230.
3
[Does treatment with piracetam in stroke patients with aphasia make sense?].[吡拉西坦治疗失语症中风患者是否合理?]
Dtsch Med Wochenschr. 2002 Dec 6;127(49):2636. doi: 10.1055/s-2002-35930.
4
Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles.吡拉西坦和左乙拉西坦:结构相似,但药理和临床特征不同。
Epileptic Disord. 2000 Jun;2(2):99-105.
5
Piracetam and platelets--a review of laboratory and clinical data.吡拉西坦与血小板——实验室及临床数据综述
Pharmacopsychiatry. 1999 Mar;32 Suppl 1:44-8. doi: 10.1055/s-2007-979236.
6
Piracetam: a novel therapy for autism?
J Autism Dev Disord. 1997 Oct;27(5):628-30.
7
The role of piracetam in the treatment of acute and chronic aphasia.吡拉西坦在急慢性失语症治疗中的作用。
Pharmacopsychiatry. 1999 Mar;32 Suppl 1:38-43. doi: 10.1055/s-2007-979235.
8
[Pharmacokinetics of the nootropic drugs].[益智药物的药代动力学]
Eksp Klin Farmakol. 1997 Nov-Dec;60(6):62-70.
9
[Effect of piracetam on urea-induced myoclonus in rats].[吡拉西坦对尿素诱导的大鼠肌阵挛的影响]
Nihon Shinkei Seishin Yakurigaku Zasshi. 2000 May;20(2):45-50.
10
Piracetam improves cognitive performance by restoring neurochemical deficits of the aged rat brain.吡拉西坦通过恢复老年大鼠大脑的神经化学缺陷来改善认知能力。
Pharmacopsychiatry. 1999 Mar;32 Suppl 1:10-6. doi: 10.1055/s-2007-979231.

引用本文的文献

1
Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs.益智药作为认知增强剂:智能药物的类型、剂量和副作用。
Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367.
2
Effects of Smart Drugs on Cholinergic System and Non-Neuronal Acetylcholine in the Mouse Hippocampus: Histopathological Approach.智能药物对小鼠海马体胆碱能系统和非神经元乙酰胆碱的影响:组织病理学方法
J Clin Med. 2022 Jun 9;11(12):3310. doi: 10.3390/jcm11123310.
3
Evaluation of Nootropic Activity of Against Scopolamine-induced Amnesia in Rats.
[物质名称]对东莨菪碱诱导的大鼠失忆症的益智活性评估。 (原文中“of”后面缺少具体物质名称)
Turk J Pharm Sci. 2021 Feb 25;18(1):3-9. doi: 10.4274/tjps.galenos.2019.30316.
4
Drug screening for Pelizaeus-Merzbacher disease by quantifying the total levels and membrane localization of PLP1.通过定量PLP1的总水平和膜定位对佩利措伊斯-梅茨巴赫病进行药物筛选。
Mol Genet Metab Rep. 2019 May 7;20:100474. doi: 10.1016/j.ymgmr.2019.100474. eCollection 2019 Sep.
5
Oral Piracetam vs Betahistine in Outpatient Management of Peripheral Vertigo; a Randomized Clinical Trial.口服吡拉西坦与倍他司汀治疗门诊周围性眩晕的随机临床试验比较
Arch Acad Emerg Med. 2019 Jan 23;7(1):e9. eCollection 2019 Winter.
6
The Conditions Under Which Piracetam Is Used and the Factors That Can Improve National Institute of Health Stroke Scale Score in Ischemic Stroke Patients and the Importance of Previously Unnoticed Factors From a Hospital-Based Observational Study in Taiwan.吡拉西坦的使用条件、可改善缺血性中风患者美国国立卫生研究院卒中量表评分的因素以及来自台湾一项基于医院的观察性研究中先前未被注意到的因素的重要性。
J Clin Med. 2019 Jan 20;8(1):122. doi: 10.3390/jcm8010122.
7
The Effect of Agomelatine Treatment on Diabetes-Induced Cognitive Impairments in Rats: Concomitant Alterations in the Hippocampal Neuron Numbers.阿戈美拉汀治疗对糖尿病诱导的大鼠认知障碍的影响:海马神经元数量的伴随变化。
Int J Mol Sci. 2018 Aug 20;19(8):2461. doi: 10.3390/ijms19082461.
8
Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.代谢增强剂吡拉西坦可减轻半胱天冬酶非依赖性通路中线粒体特异性蛋白的易位、多聚(ADP-核糖)聚合酶 1 的上调和氧化 DNA 片段化。
Neurotox Res. 2018 Aug;34(2):198-219. doi: 10.1007/s12640-018-9878-2. Epub 2018 Mar 12.
9
Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.吡拉西坦在局灶性脑缺血大鼠中的药代动力学研究
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):205-213. doi: 10.1007/s13318-017-0435-9.
10
Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic.建立天然益智药:受天然益智药影响的近期分子增强作用。
Evid Based Complement Alternat Med. 2016;2016:4391375. doi: 10.1155/2016/4391375. Epub 2016 Aug 30.